Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients

Background Anthropometric indices of central obesity, waist circumference (WC), conicity index (CI), and a-body shape index (ABSI), are prognostic indicators of cardiovascular (CV) risk. The association of CI and ABSI with other CV risk indices, markers of nutritional status and inflammation, and clinical outcomes in chronic kidney disease (CKD) stage 5 (CKD5) patients was investigated. Methods In a cross-sectional study with longitudinal follow up of 203 clinically stable patients with CKD5 (median age 56 years; 68% males, 17% diabetics, 22% with CV disease, and 39% malnourished), we investigated CI and ABSI and their associations with atherogenic index of plasma (AIP), Framingham CV risk score (FRS), Agatston scoring of coronary artery calcium (CAC) and aortic valve calcium (AVC), handgrip strength (HGS), high sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6). CV events (CVE) and all-cause mortality during up to 10-years follow up were analyzed by multivariate survival analysis of restricted mean survival time (RMST). Results Chronic kidney disease patients with middle and highest CI and ABSI tertiles (indicating greater abdominal fat deposition), compared to those with the lowest CI and ABSI tertiles, tended to be older, more often men and diabetic, had significantly higher levels of hsCRP, IL-6, AIP, FRS, CAC and AVC scores. CI and ABSI were positively correlated with CAC, FRS, AIP, hsCRP and IL-6. Both CI and ABSI were negatively correlated with HGS. In age-weighted survival analysis, higher CI and ABSI were associated with higher risk of CVE (Wald test = 4.92, p = 0.027; Wald test = 4.95, p = 0.026, respectively) and all-cause mortality (Wald test = 5.24, p = 0.022; Wald test = 5.19, p = 0.023, respectively). In RMST analysis, low vs. high and middle tertiles of CI and ABSI associated with prolonged CVE-free time and death-free time, and these differences between groups increased over time. Conclusion Abdominal fat deposit indices, CI and ABSI, predicted CV outcomes and all-cause mortality, and were significantly associated with the inflammatory status in CKD patients.

[1]  Kyunghwa Han,et al.  Restricted Mean Survival Time for Survival Analysis: A Quick Guide for Clinical Researchers , 2022, Korean journal of radiology.

[2]  P. Chiarello,et al.  Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria , 2021, Medical Principles and Practice.

[3]  D. Berman,et al.  Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. , 2021, Atherosclerosis.

[4]  A. Jayedi,et al.  Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies , 2020, BMJ.

[5]  J. Krakauer,et al.  Association of Body Shape Index (ABSI) with Hand Grip Strength , 2020, International journal of environmental research and public health.

[6]  F. Hu,et al.  Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity , 2020, Nature Reviews Endocrinology.

[7]  P. Stenvinkel,et al.  Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease. , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  L. Tereshchenko,et al.  Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis , 2018, American Journal of Nephrology.

[9]  Y. Zha,et al.  Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients , 2018, BMC Nephrology.

[10]  A. Balbi,et al.  Handgrip strength in end stage of renal disease—a narrative review , 2018, Nutrire.

[11]  Youngmee Kim,et al.  Obesity and chronic kidney disease: A population-based study among South Koreans , 2018, PloS one.

[12]  J. Caramori,et al.  Recognition of visceral obesity beyond body fat: assessment of cardiovascular risk in chronic kidney disease using anthropometry , 2017, Nutrire.

[13]  C. Zoccali,et al.  Obesity and kidney disease: hidden consequences of the epidemic , 2017, Journal of Nephrology.

[14]  O. Mohamed,et al.  Central obesity and risks of cardiovascular events and mortality in prevalent hemodialysis patients , 2017, International Urology and Nephrology.

[15]  C. Zoccali,et al.  Obesity and Kidney Disease: Hidden Consequences of the Epidemic. , 2017, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[16]  Ó. Escribano,et al.  Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular Complications , 2016, International journal of endocrinology.

[17]  J. Carrero,et al.  Sensitivity and Specificity of Body Mass Index as a Marker of Obesity in Elderly Patients on Hemodialysis. , 2016, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[18]  C. Prado,et al.  Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact , 2016, Proceedings of the Nutrition Society.

[19]  P. Stenvinkel,et al.  Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification. , 2015, Kidney international.

[20]  F. Zamani,et al.  Conicity Index and Waist‐to‐Hip Ratio Are Superior Obesity Indices in Predicting 10‐Year Cardiovascular Risk Among Men and Women , 2015, Clinical cardiology.

[21]  J. Carrero,et al.  Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients , 2015, Peritoneal Dialysis International.

[22]  F. Nuttall,et al.  Body Mass Index , 2020, Definitions.

[23]  M. Malara,et al.  Body shape index versus body mass index as correlates of health risk in young healthy sedentary men , 2015, Journal of Translational Medicine.

[24]  F. Nuttall.  Body Mass Index , 2015, Nutrition today.

[25]  F. Hu,et al.  The Epidemiology of Obesity: A Big Picture , 2015, PharmacoEconomics.

[26]  P. Raggi,et al.  Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. , 2014, Atherosclerosis.

[27]  T. Ikizler,et al.  Obesity in CKD--what should nephrologists know? , 2013, Journal of the American Society of Nephrology : JASN.

[28]  J. Carrero,et al.  Visceral fat and coronary artery calcification in patients with chronic kidney disease. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  G. Barril,et al.  Conicity index as a contributor marker of inflammation in haemodialysis patients. , 2013, Nutricion hospitalaria.

[30]  R. V. van Domburg,et al.  Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox. , 2013, International journal of cardiology.

[31]  Teresa Oliveira,et al.  Biochemistry of adipose tissue: an endocrine organ , 2013, Archives of medical science : AMS.

[32]  H. Kramer,et al.  Obesity and kidney disease: potential mechanisms. , 2013, Seminars in nephrology.

[33]  J. Krakauer,et al.  A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index , 2012, PloS one.

[34]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[35]  Antonio Pflüger,et al.  Executive Summary. , 2012, Journal of the ICRU.

[36]  Yong Zhou,et al.  Comparison of different anthropometric measures as predictors of diabetes incidence in a Chinese population. , 2011, Diabetes research and clinical practice.

[37]  W. Brown.  Framingham Heart Study. , 2011, Journal of clinical lipidology.

[38]  R. Agarwal,et al.  Diagnosing Obesity by Body Mass Index in Chronic Kidney Disease: An Explanation for the “Obesity Paradox?” , 2010, Hypertension.

[39]  J. Carrero,et al.  Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[40]  C. Zoccali,et al.  Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. , 2009, Journal of the American College of Cardiology.

[41]  M. Schulze,et al.  General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.

[42]  J. Axelsson,et al.  Waist circumference and visceral fat in CKD: a cross-sectional study. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  J. Griffith,et al.  Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  J. Griffith,et al.  Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  C. Lewis,et al.  Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. , 2008, The American journal of clinical nutrition.

[46]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[47]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[48]  A. Garg,et al.  Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.

[49]  A. Luke,et al.  Increasing body mass index and obesity in the incident ESRD population. , 2006, Journal of the American Society of Nephrology : JASN.

[50]  S. Ferreira,et al.  Gordura visceral e sndrome metablica: mais que uma simples associao , 2006 .

[51]  S. R. Ferreira,et al.  [Visceral fat and metabolic syndrome: more than a simple association]. , 2006, Arquivos brasileiros de endocrinologia e metabologia.

[52]  Y. Hu,et al.  Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[53]  J. Frohlich,et al.  [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. , 2000, Vnitrni lekarstvi.

[54]  B. Burmahl.  The big picture. , 2000, Health facilities management.

[55]  P. Stenvinkel,et al.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.

[56]  B. Lindholm,et al.  Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. , 1998, Kidney international.

[57]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[58]  K. Weiss,et al.  A new index of abdominal adiposity as an indicator of risk for cardiovascular disease. A cross-population study. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[59]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[60]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.